SCHEMBL6474769

SCHEMBL6474769

COc1ccc(C(Cl)C(=O)NC(C(=O)O)C(C)C)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP9 P14780 4/20 0.48
MMP2 P08253 3/20 0.48
MMP1 P03956 1/20 0.48
MMP3 P08254 1/20 0.48
MMP7 P09237 1/20 0.48
MMP8 P22894 1/20 0.48
MMP13 P45452 1/20 0.48
PTGS2 P35354 3/20 0.46
AKR1C3 P42330 3/20 0.46
AKR1C2 P52895 3/20 0.46
PTGS1 P23219 2/20 0.46
CDC42 P60953 1/20 0.46
RAC1 P63000 1/20 0.46
CYP1A2 P05177 1/20 0.46
TSHR P16473 1/20 0.46
SLC22A6 Q4U2R8 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.45
GPR88 Q9GZN0 1/20 0.44
NPSR1 Q6W5P4 2/20 0.44
MME P08473 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6474415 0.87 CYP2C9 (0.47) PTGS2AKR1C3AKR1C2PTGS1CDC42
SCHEMBL6481469 0.85 SMN1; SMN2 (0.52) PTGS2AKR1C3AKR1C2PTGS1CDC42
SCHEMBL7960070 0.85 GPR88 (0.59) MMP9MMP2MMP1MMP3MMP7
SCHEMBL8651874 0.84 MME (0.46) MMP9MMP2MMP1MMP3MMP7
SCHEMBL6480017 0.80 ANPEP (0.50) MMP9MMP2MMP1MMP3MME
SCHEMBL17488474 0.80 PTGS2 (0.68) PTGS2AKR1C3AKR1C2PTGS1CDC42
SCHEMBL474032 0.78 AKR1C3 (0.54) PTGS2AKR1C3AKR1C2PTGS1CDC42
SCHEMBL6476211 0.77 HPGD (0.48) PTGS2PTGS1SMN1; SMN2NPSR1MME
SCHEMBL7410707 0.76 NPSR1 (0.71) MMP9MMP2MMP1MMP3MMP7
SCHEMBL5838728 0.76 NPSR1 (0.71) MMP9MMP2MMP1MMP3MMP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6939888-B2 1-H-3-arylpirrolidine-2,4-dione derivatives BAYER AKTIENGESELLSCHAFT (DE) 2005-09-06 US disclosed
US-20040019061-A1 1-H-3-arylpirrolidine-2,4-dione derivatives FISCHER REINER (DE) 2004-01-29 US disclosed
US-6472419-B1 1-H-3-aryl-pyrrolidine-2, 4-dione derivatives as pest-control agents BAYER AKTIENGESELLSCHAFT (DE) 2002-10-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040019061-A1 1-H-3-arylpirrolidine-2,4-dione derivatives PRXL2A, DDT, CYP4B1 MMP9 3664/4885MMP2 2436/4885MMP1 3464/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.